Disclosures: Abdellatif Ismail: Nothing to Disclose, Winston Dunn: Nothing to Disclose, Gene Im: KorroBio: Consultant, Echosens: Device support for research, Ethan Weinberg: PharmaIN: Consultant, BioVie: Consultant, Sequana: Consultant, Novo Nordisk: Advisor, Allison Kwong: Nothing to Disclose, Ana Clemente: Nothing to Disclose, Shasthry Sm: Nothing to Disclose, Archana Rastogi: Nothing to Disclose, Bethany So: Nothing to Disclose, Kevin Tang: Nothing to Disclose, Rashmi Tondon: Nothing to Disclose, Suvradeep Mitra: Nothing to Disclose, Nipun Verma: Nothing to Disclose, Ajay Duseja: Nothing to Disclose, Rohit Mehtani: Nothing to Disclose, Paul Kwo: Nothing to Disclose, K Rajender Reddy: Nothing to Disclose, Ramon Bataller: Nothing to Disclose, Juan Pablo Arab: Nothing to Disclose, Patrick Kamath: Sequana: Advisor, NovoNordisk: Advisor, Shiv Kumar Sarin: Nothing to Disclose, Ashwani Singal: Nothing to Disclose, Nothing to Disclose, Nothing to Disclose, Nothing to Disclose, Nothing to Disclose, Nothing to Disclose, Nothing to Disclose, Nothing to Disclose, Nothing to Disclose, Nothing to Disclose, Nothing to Disclose, Nothing to Disclose, Nothing to Disclose 709 CLINICAL FACTORS IMPACTING THE HEALTH-RELATED QUALITY OF LIFE OF CHILDREN AND YOUNG ADULTS WITH AUTOIMMUNE LIVER DISEASE Rebecca Farr 1 Lin Fei 1 Rashmi Sahay 1 Heidi Kalkwarf 1 Kevin Hommel 1 Cyd Castro-Rojas 1 Mosab Alquraish 1 Amy Taylor 1 Alexander Miethke 1 , 1 Cincinnati Children's Hospital Medical Center Background Pediatric autoimmune liver disease (AILD) is a spectrum of rare, chronic liver diseases, ranging from autoimmune hepatitis (AIH) to primary sclerosing cholangitis (PSC)
Abstract Psoriasis is a common, chronic, and recurrent inflammatory disease
Takeda K, Shiraishi Y, Ashino S, Han J, Jia Y, Wang M, et al
Multiple studies show that melatonin supplementation significantly boosts clinical pregnancy rates in assisted reproductive treatment cycles
Notably, tdTomato+ V-organoids successfully engrafted in 67% of recipient mice (Figs
This study showed a significant increase in the GHK-Cu concentration present in the blood as a result of wearing the LifeWave X39 patch for 1 week in individuals age 40 to 80
